Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenetic Biosciences (XBIO) Invested Capital (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Invested Capital for 5 consecutive years, with $4.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital fell 43.78% year-over-year to $4.0 million, compared with a TTM value of $4.0 million through Sep 2025, down 43.78%, and an annual FY2024 reading of $6.0 million, down 38.67% over the prior year.
  • Invested Capital was $4.0 million for Q3 2025 at Xenetic Biosciences, down from $4.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $12.9 million in Q1 2023 and bottomed at $4.0 million in Q3 2025.
  • Average Invested Capital over 3 years is $8.0 million, with a median of $7.4 million recorded in 2024.
  • The sharpest move saw Invested Capital crashed 32.52% in 2024, then tumbled 43.78% in 2025.
  • Year by year, Invested Capital stood at $9.8 million in 2023, then plummeted by 38.67% to $6.0 million in 2024, then plummeted by 34.14% to $4.0 million in 2025.
  • Business Quant data shows Invested Capital for XBIO at $4.0 million in Q3 2025, $4.5 million in Q2 2025, and $5.1 million in Q1 2025.